Miniature brain models grown from patients’ cells revealed striking differences in how Alzheimer’s-related tissue responds to an antidepressant. The organoids and the particles they release could eventually guide more personalized treatments and provide new clues for diagnosing the disease.
Most Read
read also
David Malukas “never driven so...
21 July, 2026
SpaceX launches satellite repa...
21 July, 2026
طقس الخميس.. الأرصاد تعلن استم...
23 July, 2026
Teenager drops social media ad...
22 July, 2026